Vernalis PLC (VER.L)

Pharmaceuticals - Diversified

Register or Sign in to receive email alerts for items in your favourites whenever we write about them
 

Share Price

Share Intraday Performance
12.5p
+0.3p (+2.00%)
Bid: 0.0p Offer: 13.0p
As of: 18 Oct 2017 16:27
 
Market Capitalisation: £68.44 million
Shares In Issue: 526.45 million
PE: 0
Dividend Yield: 0

Share Performance

52 week high:   39.5p on 18-Oct-16
52 week low:   12.1p on 13-Oct-17

Financial History

to Jun '15to Jun '16to Jun '17
Turnover£20m£12m£21m
EPS-1.5p-3.6p-4.1p
Operating Profit-£12m-£24m-£26m
Total Operating Expense£32m£36m£47m
Net Profit-£6m-£15m-£22m
Net Profit Before Taxes-£9m-£15m-£24m
Net Profit After Taxes-£6m-£15m-£22m

Sponsored by:

Company Information
Number of Shares Out 526.45m
Number of Shares Floating 519.92m
Number of Common Share Holders 14,866
Number of Employees 115
Key Figures
Volume (10 day Avg.) 0.63404m
Turnover £20.79m
Profit Before Tax £-24.87m
EPS -4.10p
Cashflow Per Share -3.81p
Cash Per Share 11.64p